Predict your next investment

Emergo by UL company logo
HEALTHCARE | Medical Facilities & Services / Medical Practice Management & Services

See what CB Insights has to offer

About Emergo by UL

Emergo by UL is a regulatory consulting firm. It specializes in global medical device and IVD compliance. It is based in Austin, Texas.

Emergo by UL Headquarter Location

2500 Bee Cave Road Building 1, Suite 300

Austin, Texas, 78746,

United States

Latest Emergo by UL News

EMERGO by UL Teams With MedCrypt to Bolster Medical Device Cybersecurity

May 20, 2021

Share EMERGO by UL, a global medical device and healthcare technology consultancy, and proactive healthcare cybersecurity developer MedCrypt announce an alliance that offers comprehensive cybersecurity regulatory affairs, quality management, and technical solutions for medical device manufacturers. The companies’ collaboration will help manufacturers address requirements from the U.S. Food and Drug Administration (FDA) as well as other market regulators for cybersecurity risk management and mitigation capabilities of connected medical devices and systems. In 2018, the FDA released its pre-and post-market guidelines that outline issues manufacturers need to consider in the design and development of their medical devices to ensure cybersecurity vulnerabilities are adequately addressed. The post- market guidance outlines a risk-based framework to ensure manufacturers could quickly respond to new threats once a device is in use. Under this new mutual referral agreement formed by EMERGO by UL and MedCrypt, the two companies will refer prospective clients to one another and co-market their cybersecurity software solutions, consulting, and risk management services to ensure clients understand and meet the FDA’s requirements. Related Posts “While the healthcare industry has made significant strides when it comes to cybersecurity, the increase in targeted attacks in the last year alone shows us there is still significant work to be done to make security a top priority,” said  Mike Kijewski , MedCrypt’s CEO. “Healthcare companies and vendors are challenged with determining how to continue to innovate and deliver clinical therapies, but doing so while being secure. This collaboration with EMERGO by UL provides our combined networks of customers with a wider set of services that together ensure security is designed into a device throughout its entire life cycle, which is the best bet we have at moving the needle for better healthcare security.” Since late 2009, The U.S. Department of Health and Human Services (HHS) has required the reporting of data breaches that affect more than 500 patients. The data since then shows a year-over-year increase of reported breach incidents by 23% with hacking incidents now accounting for 2/3 of reported breaches. Additionally, medical device vulnerabilities that are reported regularly by ICS-CERT notes a 109% year over year increase of newly disclosed vulnerabilities.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Emergo by UL Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Emergo by UL Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.